Development of a Dosage Form of the New Antitumor Antibiotic Olivamide
Autor: | Anna N. Tevyashova, Andrey E. Shchekotikhin, E. N. Bychkova, Lyubov G. Dezhenkova |
---|---|
Rok vydání: | 2019 |
Předmět: |
Pharmacology
Drug 010405 organic chemistry medicine.drug_class Chemistry media_common.quotation_subject Antibiotics Pharmacology toxicology 01 natural sciences Olivomycin A Dosage form 0104 chemical sciences 010404 medicinal & biomolecular chemistry High specific activity Drug Discovery medicine media_common |
Zdroj: | Pharmaceutical Chemistry Journal. 52:930-935 |
ISSN: | 1573-9031 0091-150X |
DOI: | 10.1007/s11094-019-01928-x |
Popis: | Methods for selective chemical modification of the antitumor antibiotic olivomycin A(OA) were developed at GINA. The compound olivamide with advantages over starting OA was selected from series of OA analogs. The goal of the present work was to develop a dosage form of the antitumor semi-synthetic antibiotic olivamide that guaranteed the stability and high specific activity of olivamide drug substance and was designed for further comprehensive preclinical studies. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |